Trials / Sponsors / Hannah Choe, MD
Hannah Choe, MD
Academic / Other · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Leukemia, Myelodysplasia, Chronic Myelomonocytic Leukemia | Phase 2 | 2026-06-01 |
| Terminated | Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD Acute Graft Versus Host Disease, Steroid Refractory Graft Versus Host Disease | Phase 1 / Phase 2 | 2022-04-19 |